|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.92 USD | +0.43% |
|
-1.03% | +27.58% |
| 07-13 | Analyst recommendations: Biogen, Deckers Outdoor, Fortinet, Marathon Petroleum, UnitedHealth… |  |
| 07-07 | RBC Capital Adjusts Exelixis Price Target to $46 From $43, Maintains Sector Perform Rating | MT |
Company Valuation: Exelixis, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,784 | 5,174 | 7,460 | 9,510 | 11,799 | 14,056 | - | - |
| Change | - | -10.54% | 44.19% | 27.47% | 24.07% | 19.13% | - | - |
| Enterprise Value (EV) 1 | 4,317 | 3,865 | 6,465 | 8,399 | 10,740 | 13,282 | 12,340 | 11,086 |
| Change | - | -10.45% | 67.25% | 29.91% | 27.88% | 23.67% | -7.09% | -10.16% |
| P/E | 25.4x | 28.6x | 36.9x | 18.9x | 15.8x | 17.6x | 15x | 12.2x |
| PBR | 2.64x | 2.09x | 3.21x | 4.18x | 5.32x | 4.99x | 3.72x | 2.79x |
| PEG | - | -1.3x | 2.3x | 0x | 0.3x | 1.2x | 0.9x | 0.5x |
| Capitalization / Revenue | 4.03x | 3.21x | 4.08x | 4.39x | 5.09x | 5.41x | 4.8x | 4.33x |
| EV / Revenue | 3.01x | 2.4x | 3.53x | 3.87x | 4.63x | 5.11x | 4.21x | 3.42x |
| EV / EBITDA | 14.4x | 17.4x | 32.9x | 13.3x | 11.9x | 11.9x | 9.97x | 6.98x |
| EV / EBIT | 15.1x | 19.2x | 37.8x | 13.9x | 12.3x | 13.1x | 10.3x | 7.82x |
| EV / FCF | 12.8x | 17.2x | 22.1x | 12.5x | 12.3x | 16.8x | 13.2x | 7.64x |
| FCF Yield | 7.8% | 5.8% | 4.53% | 8% | 8.15% | 5.95% | 7.56% | 13.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.72 | 0.56 | 0.65 | 1.76 | 2.78 | 3.182 | 3.738 | 4.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,435 | 1,611 | 1,830 | 2,169 | 2,320 | 2,600 | 2,930 | 3,245 |
| EBITDA 1 | 300.3 | 222.4 | 196.6 | 633.4 | 901.2 | 1,118 | 1,237 | 1,588 |
| EBIT 1 | 286.7 | 201.5 | 170.9 | 604.6 | 872.2 | 1,014 | 1,195 | 1,418 |
| Net income 1 | 231.1 | 182.3 | 207.8 | 521.3 | 782.6 | 818.6 | 945.4 | 1,126 |
| Net Debt 1 | -1,467 | -1,308 | -995.3 | -1,111 | -1,059 | -773.7 | -1,716 | -2,970 |
| Reference price 2 | 18.28 | 16.04 | 23.99 | 33.30 | 43.83 | 55.92 | 55.92 | 55.92 |
| Nbr of stocks (in thousands) | 316,397 | 322,561 | 310,974 | 285,579 | 269,203 | 251,355 | - | - |
| Announcement Date | 17/02/22 | 07/02/23 | 06/02/24 | 11/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.57x | 5.11x | 11.88x | -.--% | 14.06B | |
| 32.22x | 8.13x | 25.24x | 0.05% | 53.83B | |
| 19.5x | 6.01x | 13.15x | 1.63% | 52.1B | |
| -42.48x | 13.5x | -39.59x | -.--% | 23.48B | |
| -18.22x | 4.32x | -7.57x | -.--% | 23.13B | |
| 24.24x | 4.75x | 12.54x | -.--% | 19.36B | |
| 24.39x | 4.78x | 15.56x | -.--% | 17.56B | |
| 45.88x | 18.59x | 47.88x | 0.08% | 15.2B | |
| -505.73x | 35.47x | -1462.84x | -.--% | 14.83B | |
| -76.98x | 8.2x | -73.34x | -.--% | 12.76B | |
| Average | -47.96x | 10.89x | -145.71x | 0.18% | 24.63B | |
| Weighted average by Cap. | -21.55x | 9.46x | -82.32x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EXEL Stock
- Valuation Exelixis, Inc.
Select your edition
All financial news and data tailored to specific country editions
